OUR European Commission authorized to sell vaccine Species Prevtin Beta as a booster dose. Species Prevtin Beta is a protein-based vaccine against coronavirus Developed by Sanofi and GSK. This is the seventh coronavirus vaccine approved in the EU, which covers the use of the vaccine as a booster dose for adults after initial vaccination with another coronavirus vaccine.

The marketing authorization follows the positive scientific advice of the European Medicines Agency (EMA), based on a thorough assessment of the safety, efficacy and quality of the vaccine and approved by Member States. The Commission and Member States have entered into a pre-purchase agreement with Sanofi and GSK which is effective September 18, 2020 and allows EU Member States to purchase up to 300 million doses of the vaccine if they wish.

Member States can also donate these vaccines to low- and middle-income countries. The EU portfolio now includes seven safe and effective coronavirus vaccines.

^{Source: APE-MEB}